CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

BofA Upgrades Candel Therapeutics to Buy From Neutral, Price Target is $18

Positive
AI Analysis

Summary

Bank of America upgraded Candel Therapeutics from Neutral to Buy with an $18 price target.

Importance:4/10
Sentiment:
0.70
analyst_upgradeprice_targetequity_research
Related Companies

Read the original article

Published by yahoo_finance on September 21, 2026 10:53 AM

Read Original